The Arke

News

7

Jul

Bionik Laboratories Completes US $13.1 Million Private Placement

Toronto, ON – July 7, 2015 – Bionik Laboratories Corp. (OTCBB: BNKL), a medical device and robotics company with a core focus in robotic exoskeleton technology for users with mobility impairments (“Bionik” or the “Company”), announced today that it has Read More >>

iStock_000016290758_Small

About Bionik

Bionik Laboratories is an innovative medical device company developing transformational robotic rehabilitation technologies. The company focuses on reinventing and advancing the standards of biomechatronics, and developing innovative technologies that redefine rehabilitation for patients with restricted physical mobility.

iStock_000011523945_Medium

Products

Arke

The company's lead program, ARKE is a lower body, robotic exoskeleton that allows patients with mobility impairments the ability to walk. Currently in clinical development, ARKE will initially be used in a rehabilitation environment, with the goal of being made available for home use.